Cytosorbents's total assets for Q4 2024 were $47.37M, a decrease of -0.90% from the previous quarter. CTSO total liabilities were $36.26M for the fiscal quarter, a 4.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.